ASHRAE TORONTO CHAPTER
Notice of Meeting - Dinner Only
Date: Monday April 12, 2010
Venue: Sanofi Pasteur Limited’s Toronto Campus
1755 Steeles Avenue West
Toronto, Ontario, M2R 3T4
Click Here for a Map
Tour: 4:00 PM (Separate Registration)
Mixing: 5:30 PM
Dinner: 6:30 PM
Theme: Research Promotion Night
We ask that you pre-register for the dinner and technical tour (separate registration) at your earliest convenience online at www.torontoashrae.com then select “Meetings and Events” from the left tab and the “Register” button for the April Dinner Meeting. You may also still register through the ASHRAE chapter office (Sabrina Tai - 905 602 4714 or firstname.lastname@example.org).
Dinner Speakers and Topics:
Building 95 - New Research and Development Facility
Considered one of the greatest advances in the history of medicine, vaccinations are the cornerstone of public health programs around the world. Located north of Toronto, Sanofi Pasteur is a leading site for production and research and development (R&D) in the human vaccines industry. Sanofi Pasteur is the vaccine division of France-based Sanofi-Aventis Group, one of the world's largest pharmaceutical companies. Sanofi Pasteur develops and manufactures vaccines that protect against a myriad of infectious diseases, most prominently influenza, polio, and meningitis. Its most commonly distributed products include flu vaccines, childhood combination vaccines and adult booster shots, in addition to traveler’s vaccines which protect against typhoid, cholera and yellow fever. Sanofi Pasteur is committed to continuously researching and developing new products to improve existing vaccines, preventative vaccines for HIV and dengue fever, and therapeutic vaccines for cancer. In 2008, Sanofi Pasteur produced enough vaccine to immunize more than 500 million people worldwide. The Toronto site, which employs over 1,100 people, is one of Sanofi Pasteur's most historical and strategic sites.
In 2008, Sanofi Pasteur invested $100M in the construction of a state-of-the-art research facility, coded Building 95, at the company’s historic Connaught Campus in Toronto, Ontario. The investment included the construction of an $80M facility, the purchase of specialized research & development (R&D) equipment, and the support of high-value R&D jobs over the next five years. For this project, sanofi pasteur partnered with the Government of Ontario, which contributed over $13M through the Biopharmaceutical Investment Program (BIP) - administered by the Ministry of Research and Innovation and part of the government's Next Generation of Jobs Fund. Research conducted at the new facility will help support the company’s global research and development efforts to improve existing vaccines and create new vaccines. Research targets will include pediatric combination vaccines, pneumococcal protein vaccines, and cancer vaccines. The new facility is part of an ongoing commitment to research and development in the area of immunology. Construction of the 165,000 square-foot (15,000 square-meter) facility began in 2008 and is projected for occupancy in March 2010.
The dinner speakers for this meeting include: Norm Medeiros, Senior Director of Facilities Management and Engineering Services at Sanofi Pasteur; David Brodie, Senior Director and General Manager of R&D at Sanofi Pasteur; and Andrew Pratt, Vice President and Mechanical Principal at Crossey Engineering Limited. Mr Medeiros and Mr. Brodie will provide the membership with a general understanding of Sanofi Pasteur's Toronto campus, products and services, R&D activities and the vision and motivations surrounding the B95 initiative. Mr. Pratt will be providing a complete summary of the mechanical systems designed and installed within the B95 facility.
Dinner Speaker Biographies:
Norm Medeiros is responsible for the effective operations of Engineering Services, Maintenance Services, Utility & General Services, Security, Facility Systems and Planning and Environment Health & Safety. Mr. Medeiros ensures the development and successful implementation of the sites approved master site plan and the capital programs required to fund the ongoing business strategies. Prior to joining sanofi pasteur in 2001, Mr. Medeiros was Global Operations Director for Warner Lambert Co./Pfizer where he was responsible for the introduction and implementation of new technologies to the manufacturing sector. Mr. Medeiros, having graduated in 1977, holds a Bachelor of Engineering degree from Michigan Technological University and a Masters of Engineering specializing in Advanced Manufacturing Engineering from University of Western Ontario.
Joining Sanofi Pasteur Limited in 1982, then known as Connaught Laboratories, after completing a PhD in Cell Biology from the University of Western Ontario, David Brodie has held many leadership roles during his 28 years on the campus within various corporate divisions, including R&D Project Leadership; Industrial Operations Filling and Packaging; Bulk Vaccine Manufacturing; Insulin Manufacturing; and Corporate Systems Projects. Most recently, Mr. Brodie assumed the role of Project Director for the B95 and B96 Research and Development Facility initiatives – the latest R&D infrastructure additions to Sanofi Pasteur’s Toronto campus. Mr. Brodie's roles and responsibilities included directing Steering Committee activities, coordinating functional planning, assuring appropriate funding and resourcing, and accepting overall project execution performance evaluation. The successful completion of both projects directly reflects Mr. Brodie's ability to maintain strong communication and cohesiveness between all major project groups including Engineering, R&D, Quality Assurance, Regulatory Affairs, Purchasing, Legal, Finance and Senior Management. Other notable accomplishments throughout Mr. Brodie's career include the implementation Sanofi Pasteur’s corporate enterprise resource management solution (SAP) at a Class A MRPII level and leading various R&D vaccine candidate initiatives (i.e.: Adacel and RSV).
Andrew Pratt graduated from the University of Western Ontario in 1989 and joined Crossey Engineering upon graduation. He has been working with Crossey Engineering for the past 20 years and became a Vice President with the firm in 2008. Mr. Pratt’s work experience includes projects in the Pharmaceutical, Laboratory, University, Performing Arts, Commercial Office and Hospital and Long-term care sectors. Mr. Pratt's pharmaceutical and lab experience includes projects for Sanofi Pasteur, Novopharm, Glaxo Smith Kline, Patheon and Apotex. Some of the recent non-pharmaceutical projects he has been involved with are the Four Seasons Centre for the Performing Arts in Toronto, Orchestra Hall in Detroit, National Ballet School in Toronto and the Revitalization of Nathan Phillips Square. As Vice President of Crossey Engineering, Mr. Pratt assumes the role of Principal in Charge. He is directly involved in projects taking part in all conceptual design and design development discussions and supervising their implementation. He is also responsible for ensuring that adequate resources are available for the Mechanical team to complete their tasks on time, acts as resource for questions and as a contact for the client for any mechanical issues. For the B95 project, Mr. Pratt was directly involved in all phases of the project from conceptual design through working drawings and participated in site supervision of the mechanical system installation.
Special Notices for the Event:
1) Parking Requirements: All technical tour and dinner event attendees may park in either the visitor parking lot or the designated employee parking spaces as outlined within the parking map below.
2) Sign-in Requirements: All technical tour and dinner event attendees must sign into the Building 4 Security Guardhouse upon entering the site (NW corner of site as outlined within the map below). Security will have pre-assigned visitor badges available for all event attendees. Dinner event attendees should be on-site no later than 6:30 PM.
Attention: All interested members and guests MUST pre-register online to attend this event (by April 11th, 2010). Absolutely NO walk-in visitors will be allowed to access the site, technical tour and dinner meeting.
3) Photos and Videos are Strictly Prohibited: No cameras, photos and video cameras are allowed on-site – both at the dinner meeting and throughout the technical tour. If any devices are found, they will be immediately confiscated by Security.
4) Unescorted Travelling On-site is Strictly Prohibited: Event attendees cannot travel unescorted throughout the many buildings and pathways across the site. There will be additional Security, volunteers and visible signage available to escort and guide attendees to all required locations. Individuals found wandering throughout the site will be asked to leave. Upon signing in at the Building 4 Security Guardhouse, event attendees will be guided to Building 83’s Cafeteria Dining Room, where attendees will congregate prior to both the technical tour and the dinner meeting event.